BIONOTE, Presents on the Topic of POC PCR at the Korean Society of Veterinary Science Fall Academic Conference

▶ Presented on the topic of molecular diagnostics market trends and changes in POC PCR equipment technology▶ Announced plans to accelerate global business by expanding reagent parameters of Vcheck M10 amid expanding veterinary molecular diagnostics marketGlobal leader in Veterinary Diagnostics and Biological Raw Materials BIONOTE Inc., announced on the 8th of December, that they presented on the topic of POC PCR (Pointe of Care Polymerase Chain Reaction) at the 2023 Korean Society of Veterinary Science Fall Academic Conference, held at the Jeju International Convention Center on the 29th of November to 2nd of December.  At this year's conference, a total of 19 academic sessions were held under the theme of "Advanced Fusion and Technology of Veterinary Biomedical Research".   BIONOTE's resident DVM, Dr. Angela Moon, presented at the "Field Application fo Advanced Molecular Diagnostic Technology for Animal Diseases" session of Symposium 13, on the topic of "Point of Care Testing Application Trends of PCR In Companion Animal Disease Diagnosis".  The primary focus was on the market trends of molecular diagnostics in the global veterinary market and changes in Point of Care PCR equipment technology.    The global veterinary molecular diagnostics market size is expected to grow from 300 billion KRW in 2021 to 540 billion KRW by 2026, with an average annual growth of 10%.  In addition, 95% of all PCR tests are currently referred to diagnostic laboratories, and only about 5% are carried out using POC equipment. However, as improved POC PCR equipment continues to be developed, a significant change in the market share is expected within the next 5 years.    Vcheck M10, launched by BIONOTE in the second half of last year, is a Real-time PCR device that performs nucleic acid extraction, amplification, and results analysis all within an hour using a single device. It is also characterized by the ability to scale up depending on the needs of the customer, from specialized laboratories to small and large vet clinics, through the expansion of up to 8 channels. A BIONOTE spokesperson stated, " We plan on continuing to expand the reagent parameters to accelerate our global business growth" and "We are also planning to launch our Babesia gibsoni ​cartridge and enter the domestic market after acquiring the necessary regulatory clearance". 

• 2023.12.08
• Hits : 5,401

BIONOTE attends the largest veterinary conference in Latin America

▶ Attended the Congreso Veterinario de León, held in Mexico for 4 days between the 6th and 9th of September▶ Intends to continue to increase supply and service towards end-users... continue to increase M/S in Latin America Global leader in Veterinary Diagnostics and Biological Raw Materials BIONOTE Inc., announced today that they participated in Congreso Veterinario de León (CVDL), the largest veterinary conference in Latin America.The Conference was held in León, Mexico for 4 days between the 6th and 9th of September.CVDL is the largest veterinary conference in Latin America, held every year in León Mexico​ since 1995. This conference is a gathering of over 900 veterinary companies from all over South and Central Americas, including Mexico, as well as veterinarians from around the World, with over 30 academic seminars.  Through this conference, BIONOTE was able to promote their rapid diagnostic tests (RDTs), fluorescent immunoassay platform Vcheck F, Point of Care (POC) molecular diagnostic platform Vcheck M as well as the soon to be launched Vcheck C, the versatile high-throughput chemistry analyzer.  Furthermore, BIONOTE was able to receive valuable feedback and insight regarding their current products from the veterinarian end-users, as well as have meaningful discussions with BIONOTE's Latin American dealers regarding future plans and strategies to increase M/S & to successfuly launch the newest products.   A BIONOTE spokesperson commented that "the Latin American market is rapidly expanding" and that "BIONOTE will continue to not only provide excellent quality products, but to also provide the necessary training, academic support and services for the customers in order to strengthen our position in the Latin American market while increasing M/S". 

• 2023.09.11
• Hits : 5,933

BIONOTE signs supply agreement with one of the three largest distributors in the US

BIONOTE signs supply agreement with one of the three largest distributors in US▶ Technology, performance, and marketability of BIONOTE's products highly valued... will continue to increase market share​Global leader in Veterinary Diagnostics and Biological Raw Materials BIONOTE Inc., announced on the 25th of April that they have signed a supply agreement with Covetrus, one of the three largest distributors in the United States, expanding their sales potential for animal diagnostics in the US market.Covetrus is one of the largest distributors of animal pharmaceuticals and diagnostic products in the world with revenue of over 4 billion USD, as of 2021, supplying products to North America, Europe, and Asia. Key customer bases include animal hospitals, clinics, pharmaceutical companies, pharmacies, and pet stores. Furthermore, they also provide medical information technology solutions, financial and management software for animal hospitals.BIONOTE plans to provide their veterinary fluorescent immunoassay series, 'Vcheck F', through this supply agreement. Vcheck F is a series of products, based on immunochromatic assay technology, capable of producing accurate results through the use of highly sensitive fluorescent materials. A total of 27 markers for cardiac diseases, inflammation, etc. can be tested quantitatively, as well as qualitatively using the Vcheck F series.BIONOTE plans to expand their presence in the market and increase sales of their various products, through cooperation with Covetrus for maximizing marketing and promotional activities.Dr. Byungki Cho, CEO of BIONOTE commented that "the supply agreement between Covetrus and BIONOTE is a testament to the excellence in technology, performance and marketability of BIONOTE's products" and that "BIONOTE will continue to strive to use this opportunity to increase the market share of our products in the US market".

• 2023.04.26
• Hits : 4,700